First measurement of cancer biomarkers in whole blood

A team led by Yale University researchers has used nanosensors to measure cancer biomarkers in whole blood for the first time. Their findings could dramatically simplify the way physicians test for biomarkers of cancer and other diseases.

Related Posts

Comments are closed.